Oliceridine
Oliceridine
Oliceridine (pronounced: oh-lih-seh-ri-deen) is a G protein biased mu-opioid receptor agonist that is used for the management of moderate to severe acute pain in adults. It is marketed under the brand name Olinvyk.
Etymology
The name "Oliceridine" is derived from the Latin word "Oleo", meaning "oil", and the Greek word "Eridanos", meaning "river". This is a reference to the drug's ability to flow through the body like a river, providing pain relief.
Pharmacology
Oliceridine works by selectively binding to the mu-opioid receptor in the brain and spinal cord. This binding action inhibits the transmission of pain signals to the brain, thereby reducing the perception of pain. Unlike traditional opioids, Oliceridine is designed to minimize the risk of respiratory depression and gastrointestinal side effects.
Usage
Oliceridine is indicated for the management of acute pain severe enough to require an intravenous opioid analgesic and for patients for whom alternative treatments are inadequate. It is administered intravenously in a hospital or other controlled clinical setting.
Side Effects
Common side effects of Oliceridine include nausea, vomiting, dizziness, headache, constipation, and excessive sweating. Serious side effects may include respiratory depression and addiction.
Related Terms
External links
- Medical encyclopedia article on Oliceridine
- Wikipedia's article - Oliceridine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski